Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

NCT00211484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Age-Related Macular Degenerations.
Subfoveal Neovascularization.

Interventions

DRUG: Anecortave Acetate

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]